Live Quote · NASDAQHKPDHealthcare· Medical - Pharmaceuticals

Cellyan Biotechnology Co., Ltd

$0.44 8.54%(+$0.03)
TickerSpark Score
53/100
Mixed
100
Valuation
25
Profitability
50
Growth
60
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HKPD research report →

52-Week Range5% of range
Low
$0.32
Current
$0.44
High
$2.58
Company Overviewwww.9zt.hk

About the company

Cellyan Biotechnology Co. , Ltd, an investment holding entity, primarily operates within the over-the-counter (OTC) pharmaceutical sector, serving markets across Hong Kong and mainland China. The company's services encompass the international sourcing and distribution of OTC medications, alongside comprehensive e-commerce supply chain management.

CEO
Chenyu Liang
IPO
2025
Employees
27
HQ
Yau Tong, HK

Price Chart

-64.26% · this period
$1.74$1.04$0.33Jul 02Dec 31Jul 02
Valuation
Market Cap
$4.83M
P/E
-162.81
P/S
0.24
P/B
0.79
EV/EBITDA
5.35
Div Yield
0.00%
Profitability
Gross Margin
11.89%
Op Margin
0.65%
Net Margin
-0.13%
ROE
-0.59%
ROIC
-1.34%
Growth & Income
Revenue
$20.31M · 21.72%
Net Income
$-27,056 · -102.03%
EPS
$-0.00 · -101.50%
Op Income
$132.04K
FCF YoY
185.88%
Performance & Tape
52W High
$2.58
52W Low
$0.32
50D MA
$0.52
200D MA
$0.82
Beta
2.48
Avg Volume
366.63K

Get TickerSpark's AI analysis on HKPD

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Mar 18, 26CHAN Kam Leungother0
Mar 18, 26Wong Lap Sunother0
Mar 18, 26Wang Zifengother0
Mar 18, 26Liu Shuother0
Mar 18, 26Zhou Mike Yaoother0
Mar 18, 26Wu Jingyanother0
Mar 18, 26Liang Chenyu Andyother0
Coverage · HKPD

Our HKPD coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on HKPD yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate HKPD report →
Internal Compare

Similar companies

Peers in the same neighborhood.